Can a monthly shot protect kidneys in polycystic disease?
NCT ID NCT02127437
First seen Apr 18, 2026 · Last updated May 19, 2026 · Updated 6 times
Summary
This study tested whether lanreotide, a monthly injection, can slow the loss of kidney function in people with autosomal dominant polycystic kidney disease (ADPKD). The trial included 159 adults with moderate kidney decline and measured changes over three years. Researchers also tracked safety, blood pressure, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Necker hospital
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.